|
|
Office Locations:
|
40 West 57th Street, Suite 1810
New York, NY 10019
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
PBM Capital is a healthcare-focused investment firm that invests in companies in the pharmaceutical and life sciences industries. Paul Manning, who built PBM Products from scratch with less than $1 million invested and grew it to the world's leading provider of private label infant formula, supplying products to over 50,000 retail stores. PBM Products was sold to Perrigo, a publicly listed pharmaceutical company, for over $800 million. After this transaction, Paul formed PBM Capital in 2010 to provide dedicated capital to healthcare investments. PBM Capital currently has several platform operating companies developing life-changing pharmaceutical and biological products. Since 2010, PBM and its portfolio companies have created more than $10 Billion in shareholder value.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
